Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000578801 | SCV000681014 | pathogenic | not provided | 2023-08-28 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 36553453, 26424145) |
Genetics Laboratory, |
RCV000207215 | SCV002577709 | pathogenic | Spastic paraplegia-severe developmental delay-epilepsy syndrome | 2022-10-04 | criteria provided, single submitter | clinical testing | PVS1;PM2_supporting;PM3 |
Labcorp Genetics |
RCV000578801 | SCV004294644 | pathogenic | not provided | 2023-01-03 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Arg748*) in the HACE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HACE1 are known to be pathogenic (PMID: 26424145, 26437029). This premature translational stop signal has been observed in individual(s) with HACE1-related disease (PMID: 26424145). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 221290). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000207215 | SCV000262621 | pathogenic | Spastic paraplegia-severe developmental delay-epilepsy syndrome | 2016-02-04 | no assertion criteria provided | literature only |